ADALIMUMAB-FKJP

ADALIMUMAB-FKJP was reported 45915 times

ADALIMUMAB-FKJP is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 476 0.7126
1 LUPUS VULGARIS 846 0.6714
2 GRIP STRENGTH 139 0.6070
3 RED BLOOD CELL SEDIMENTATION RATE 167 0.5986
4 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 67 0.5583
5 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 185 0.5506
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1085 0.5417
7 SYNOVIAL FLUID ANALYSIS 46 0.5287
8 HEPATIC ENZYME 77 0.5168
9 SWOLLEN JOINT COUNT INCREASED 1635 0.5122
10 C-REACTIVE PROTEIN 459 0.4951
11 RHEUMATIC FEVER 2194 0.4917
12 FACET JOINT SYNDROME 1544 0.4738
13 HYPOCHOLESTEROLAEMIA 160 0.4533
14 SWOLLEN JOINT COUNT 111 0.4440
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 919 0.4431
16 RETINITIS 707 0.4089
17 PARADOXICAL PSORIASIS 191 0.4072
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2809 0.3917
19 DISLOCATION OF VERTEBRA 883 0.3868
20 RHEUMATOID FACTOR POSITIVE 2161 0.3737
21 X-RAY ABNORMAL 665 0.3715
22 DUODENAL ULCER PERFORATION 2739 0.3679
23 MUSCULOSKELETAL DEFORMITY 86 0.3675
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 201 0.3583
25 BODY HEIGHT BELOW NORMAL 189 0.2939
26 ILEOCAECAL RESECTION 101 0.2936
27 PEMPHIGUS 3637 0.2906
28 C-REACTIVE PROTEIN ABNORMAL 1821 0.2836
29 PERIPHERAL VENOUS DISEASE 1151 0.2816
30 SERONEGATIVE ARTHRITIS 321 0.2801
31 HELICOBACTER INFECTION 2766 0.2689
32 HAND DEFORMITY 3481 0.2651
33 SHORT STATURE 69 0.2634
34 CUTANEOUS LEISHMANIASIS 66 0.2609
35 VAGINAL FLATULENCE 76 0.2508
36 FOLLICULITIS 2621 0.2497
37 MUSCLE INJURY 2045 0.2466
38 STEROID DEPENDENCE 213 0.2426
39 BONE EROSION 821 0.2319
40 SYNOVITIS 3971 0.2200
41 AMAUROSIS FUGAX 236 0.2191
42 LOOSE BODY IN JOINT 58 0.2180
43 SARCOID-LIKE REACTION 55 0.2132
44 BREAST CANCER STAGE III 1334 0.2058
45 JOINT DESTRUCTION 314 0.2018
46 ENTHESOPATHY 306 0.1955
47 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1257 0.1934
48 TERMINAL ILEITIS 117 0.1906
49 JUVENILE IDIOPATHIC ARTHRITIS 455 0.1859
50 ANKLE ARTHROPLASTY 65 0.1791
51 PERICARDITIS 2998 0.1783
52 SAPHO SYNDROME 44 0.1781
53 PORPHYRIA ACUTE 254 0.1770
54 CATARRH 155 0.1715
55 LIP DRY 1558 0.1714
56 GRANULOMA SKIN 139 0.1693
57 GLOSSODYNIA 3785 0.1689
58 GRIP STRENGTH DECREASED 1482 0.1682
59 HYPERCHOLESTEROLAEMIA 1592 0.1647
60 PALMOPLANTAR PUSTULOSIS 83 0.1569
61 JOINT RANGE OF MOTION DECREASED 2092 0.1558
62 DRUG TOLERANCE DECREASED 438 0.1558
63 MYCOBACTERIUM MARINUM INFECTION 50 0.1538
64 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 354 0.1535
65 WOUND INFECTION 1678 0.1531
66 ONYCHOMADESIS 640 0.1523
67 BURSITIS 1756 0.1446
68 FAECAL CALPROTECTIN ABNORMAL 60 0.1446
69 PROCTOCOLECTOMY 43 0.1410
70 BLEPHAROSPASM 872 0.1383
71 DRUG SPECIFIC ANTIBODY 187 0.1365
72 GENERALISED PUSTULAR PSORIASIS 39 0.1345
73 IRIS ADHESIONS 68 0.1326
74 PLASMABLASTIC LYMPHOMA 47 0.1313
75 LIVE BIRTH 1085 0.1296
76 ANASTOMOTIC STENOSIS 47 0.1263
77 POLYCHONDRITIS 52 0.1232
78 WOUND 3430 0.1226
79 SYSTEMIC LUPUS ERYTHEMATOSUS 4215 0.1186
80 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1290 0.1165
81 AUTOIMMUNE DISORDER 1122 0.1150
82 PYODERMA GANGRENOSUM 412 0.1144
83 NEUROSARCOIDOSIS 43 0.1144
84 FIBROMYALGIA 2756 0.1133
85 IRRITABLE BOWEL SYNDROME 2407 0.1121
86 CONTRAINDICATED PRODUCT ADMINISTERED 3369 0.1112
87 BLOOD PARATHYROID HORMONE DECREASED 163 0.1099
88 MEAN PLATELET VOLUME DECREASED 92 0.1097
89 FINGER DEFORMITY 517 0.1066
90 DISSEMINATED TUBERCULOSIS 273 0.1063
91 VASCULAR ACCESS COMPLICATION 86 0.1062
92 ANTIBODY TEST POSITIVE 176 0.1060
93 ONYCHOMYCOSIS 463 0.1054
94 DEATH NEONATAL 145 0.1042
95 INFUSION SITE REACTION 309 0.1033
96 TENOSYNOVITIS 285 0.1032
97 HEPATOSPLENIC T-CELL LYMPHOMA 38 0.1024
98 LUPUS-LIKE SYNDROME 929 0.1023
99 ARTHRITIS ENTEROPATHIC 33 0.1012
100 NAIL DISORDER 879 0.1004
101 POLYARTHRITIS 522 0.0989
102 LIVER INJURY 2430 0.0989
103 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 33 0.0985
104 SACROILIITIS 185 0.0979
105 OBESITY 1522 0.0954
106 PSORIATIC ARTHROPATHY 3846 0.0947
107 RHEUMATOID LUNG 90 0.0942
108 TENOSYNOVITIS STENOSANS 52 0.0934
109 PANNICULITIS 224 0.0925
110 RHEUMATOID NODULE 253 0.0918
111 PUSTULAR PSORIASIS 311 0.0905
112 VISCERAL LEISHMANIASIS 64 0.0886
113 BURNS SECOND DEGREE 155 0.0883
114 EXOSTOSIS 781 0.0854
115 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 38 0.0848
116 VULVAL DISORDER 56 0.0847
117 TYPE 2 DIABETES MELLITUS 2796 0.0830
118 BONE DENSITY INCREASED 33 0.0827
119 FAECAL CALPROTECTIN INCREASED 260 0.0820
120 SPONDYLOARTHROPATHY 49 0.0817
121 PLEUROPERICARDITIS 33 0.0801
122 OVERLAP SYNDROME 55 0.0786
123 DACTYLITIS 77 0.0784
124 PRODUCT LABEL CONFUSION 456 0.0782
125 IMPAIRED HEALING 2560 0.0779
126 INTESTINAL ANASTOMOSIS 50 0.0776
127 HISTOPLASMOSIS DISSEMINATED 122 0.0768
128 SCIATICA 1220 0.0765
129 ILEAL ULCER 77 0.0761
130 SYNOVIAL DISORDER 33 0.0725
131 MATERNAL EXPOSURE TIMING UNSPECIFIED 271 0.0721
132 SPONDYLITIS 260 0.0714
133 THERAPEUTIC PRODUCT EFFECT DECREASED 3195 0.0713
134 IGA NEPHROPATHY 118 0.0711
135 ILEAL STENOSIS 125 0.0703
136 FOOT DEFORMITY 769 0.0693
137 PULMONARY FIBROSIS 1328 0.0692
138 ALANINE AMINOTRANSFERASE ABNORMAL 144 0.0682
139 ARTHROPATHY 3759 0.0676
140 BACK INJURY 729 0.0670
141 SCLERITIS 106 0.0661
142 ANAL STENOSIS 35 0.0657
143 WALKING AID USER 432 0.0655
144 DRUG SPECIFIC ANTIBODY PRESENT 424 0.0651
145 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 32 0.0650
146 C-REACTIVE PROTEIN INCREASED 2359 0.0648
147 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 38 0.0643
148 LOSS OF THERAPEUTIC RESPONSE 202 0.0633
149 ENTEROCUTANEOUS FISTULA 55 0.0624
150 BREAST CANCER STAGE II 511 0.0614
151 JOINT DISLOCATION 649 0.0613
152 IRIDOCYCLITIS 192 0.0607
153 DRUG TOLERANCE 307 0.0606
154 AXIAL SPONDYLOARTHRITIS 53 0.0603
155 LOWER LIMB FRACTURE 1153 0.0599
156 FEMALE GENITAL TRACT FISTULA 100 0.0585
157 POLYARTERITIS NODOSA 34 0.0582
158 PRESCRIBED OVERDOSE 1105 0.0570
159 LARGE INTESTINAL STENOSIS 114 0.0570
160 MEAN CELL VOLUME DECREASED 87 0.0564
161 COELIAC DISEASE 549 0.0559
162 POUCHITIS 48 0.0557
163 ENCEPHALITIS AUTOIMMUNE 73 0.0555
164 INFUSION RELATED REACTION 3679 0.0554
165 GAIT INABILITY 1829 0.0547
166 ERYTHRODERMIC PSORIASIS 45 0.0546
167 VARICELLA ZOSTER VIRUS INFECTION 112 0.0540
168 HIDRADENITIS 492 0.0539
169 ULCER HAEMORRHAGE 364 0.0537
170 EYE INJURY 163 0.0536
171 MEAN CELL HAEMOGLOBIN DECREASED 98 0.0535
172 PULMONARY SARCOIDOSIS 60 0.0534
173 BLOOD CHOLESTEROL INCREASED 2468 0.0529
174 PROCTITIS 148 0.0528
175 HYPERSENSITIVITY PNEUMONITIS 60 0.0527
176 GENITAL ULCERATION 40 0.0519
177 LIVER FUNCTION TEST INCREASED 1116 0.0519
178 RHEUMATOID ARTHRITIS 5848 0.0515
179 HIP ARTHROPLASTY 779 0.0508
180 GRANULOMA 173 0.0499
181 GRANULOMATOUS LIVER DISEASE 35 0.0497
182 FRACTURE DELAYED UNION 42 0.0497
183 CHORIORETINITIS 32 0.0496
184 URINARY TRACT DISORDER 221 0.0490
185 TREATMENT FAILURE 4010 0.0484
186 BLOODY DISCHARGE 55 0.0481
187 OSTEOARTHRITIS 2040 0.0481
188 LOWER RESPIRATORY TRACT INFECTION 2160 0.0474
189 HEPATIC ENZYME INCREASED 3121 0.0457
190 LYMPH NODE TUBERCULOSIS 34 0.0457
191 HENOCH-SCHONLEIN PURPURA 100 0.0457
192 NIGHT SWEATS 1472 0.0456
193 PARADOXICAL DRUG REACTION 168 0.0456
194 PRESCRIBED UNDERDOSE 908 0.0455
195 UVEITIS 611 0.0450
196 INFLAMMATION 2321 0.0449
197 DRUG INTOLERANCE 4342 0.0449
198 DEMYELINATION 183 0.0446
199 HYPOPNOEA 154 0.0443
200 BLISTER 2492 0.0443
201 HEPATIC CIRRHOSIS 832 0.0442
202 RASH VESICULAR 213 0.0440
203 MOBILITY DECREASED 3138 0.0436
204 JOINT EFFUSION 297 0.0430
205 OSTEOPOROTIC FRACTURE 82 0.0428
206 GASTROINTESTINAL WALL THICKENING 64 0.0427
207 CUSHINGOID 135 0.0420
208 DISCOMFORT 2543 0.0416
209 SKIN NECROSIS 216 0.0416
210 DERMATITIS PSORIASIFORM 85 0.0416
211 INFECTION REACTIVATION 47 0.0410
212 INTESTINAL DILATATION 54 0.0405
213 CONGENITAL ANOMALY 313 0.0404
214 THERAPY NON-RESPONDER 1807 0.0402
215 WHEELCHAIR USER 178 0.0400
216 NEUROENDOCRINE CARCINOMA OF THE SKIN 39 0.0398
217 PULMONARY TUBERCULOSIS 167 0.0391
218 WHEEZING 2313 0.0390
219 MYCOBACTERIAL INFECTION 67 0.0389
220 SWELLING 3520 0.0376
221 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 49 0.0372
222 ALLERGY TO CHEMICALS 46 0.0369
223 KNEE ARTHROPLASTY 773 0.0367
224 CYSTOID MACULAR OEDEMA 69 0.0366
225 NORMAL NEWBORN 199 0.0366
226 MATERNAL EXPOSURE DURING PREGNANCY 3254 0.0365
227 STOMATITIS 2207 0.0364
228 TASTE DISORDER 733 0.0361
229 MACULAR DEGENERATION 430 0.0360
230 ANAL FISTULA 192 0.0359
231 ALCOHOL POISONING 96 0.0358
232 CUTANEOUS T-CELL LYMPHOMA 45 0.0357
233 ANAL ABSCESS 192 0.0356
234 PNEUMONIA LEGIONELLA 57 0.0356
235 INJURY 2491 0.0354
236 ADVERSE REACTION 468 0.0353
237 CHRONIC SINUSITIS 132 0.0351
238 ILEOSTOMY 89 0.0348
239 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 260 0.0346
240 MUSCULOSKELETAL STIFFNESS 2992 0.0341
241 JOINT SWELLING 4122 0.0341
242 INTESTINAL FISTULA 48 0.0341
243 INTENTIONAL PRODUCT USE ISSUE 2950 0.0336
244 JOINT STIFFNESS 883 0.0336
245 CHOLANGITIS SCLEROSING 69 0.0336
246 STENOSIS 63 0.0335
247 SMALL INTESTINAL RESECTION 39 0.0334
248 COLITIS ULCERATIVE 1495 0.0334
249 LUNG DISORDER 1637 0.0334
250 VULVOVAGINAL CANDIDIASIS 45 0.0333
251 BRONCHIECTASIS 223 0.0331
252 HAEMORRHAGIC STROKE 256 0.0327
253 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 562 0.0327
254 ANKYLOSING SPONDYLITIS 432 0.0327
255 ILL-DEFINED DISORDER 1963 0.0323
256 MUSCULOSKELETAL PAIN 1654 0.0315
257 LIMB DEFORMITY 50 0.0314
258 ADRENAL INSUFFICIENCY 379 0.0312
259 OEDEMA 1687 0.0311
260 LATENT TUBERCULOSIS 65 0.0310
261 RADICULOPATHY 81 0.0307
262 DRUG-INDUCED LIVER INJURY 961 0.0306
263 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 44 0.0306
264 ROAD TRAFFIC ACCIDENT 1276 0.0305
265 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 81 0.0304
266 GENERAL PHYSICAL HEALTH DETERIORATION 3463 0.0299
267 LISTERIOSIS 33 0.0298
268 INFLAMMATORY MARKER INCREASED 145 0.0292
269 LIVER DISORDER 1290 0.0291
270 ATYPICAL MYCOBACTERIAL INFECTION 41 0.0290
271 FREQUENT BOWEL MOVEMENTS 783 0.0290
272 SUDDEN HEARING LOSS 58 0.0286
273 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2035 0.0286
274 DISABILITY 564 0.0285
275 INFLAMMATORY BOWEL DISEASE 279 0.0285
276 MYOSITIS 252 0.0281
277 ANTINUCLEAR ANTIBODY POSITIVE 91 0.0280
278 SARCOIDOSIS 132 0.0278
279 SLEEP DISORDER 1945 0.0275
280 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1318 0.0274
281 ERYTHEMA NODOSUM 96 0.0273
282 INTESTINAL STENOSIS 115 0.0272
283 DELIRIUM 940 0.0271
284 EPILEPSY 823 0.0269
285 SPINAL FUSION SURGERY 109 0.0268
286 GENERAL SYMPTOM 201 0.0268
287 ALOPECIA AREATA 47 0.0268
288 MULTIPLE-DRUG RESISTANCE 82 0.0264
289 MYELITIS TRANSVERSE 37 0.0262
290 MACULAR OEDEMA 146 0.0260
291 HISTOPLASMOSIS 46 0.0260
292 SUSPECTED OFF LABEL USE 117 0.0259
293 MONOCYTE COUNT INCREASED 92 0.0253
294 KERATOPATHY 40 0.0253
295 HEPATITIS 647 0.0253
296 INTERNATIONAL NORMALISED RATIO FLUCTUATION 52 0.0251
297 GASTROINTESTINAL DISORDER 2249 0.0251
298 OSTEOPOROSIS 1014 0.0246
299 EXPOSURE DURING PREGNANCY 1532 0.0246
300 ARTHRITIS 1936 0.0246
301 LYME DISEASE 81 0.0243
302 CERVICAL DYSPLASIA 53 0.0243
303 RHINITIS 195 0.0242
304 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 57 0.0240
305 EAR INFECTION 628 0.0236
306 ABDOMINAL DISCOMFORT 3951 0.0235
307 PAPILLOMA VIRAL INFECTION 38 0.0230
308 DRY MOUTH 1847 0.0227
309 ARTHRITIS BACTERIAL 93 0.0226
310 TONGUE DISORDER 163 0.0225
311 DERMATOMYOSITIS 57 0.0225
312 DEFORMITY 208 0.0222
313 CYTOMEGALOVIRUS COLITIS 51 0.0222
314 PLEURITIC PAIN 61 0.0221
315 ANTIPHOSPHOLIPID SYNDROME 35 0.0218
316 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 50 0.0215
317 ENTERITIS 137 0.0214
318 EAR PAIN 415 0.0213
319 IMMUNODEFICIENCY 318 0.0213
320 OCULAR DISCOMFORT 239 0.0213
321 RHEUMATIC DISORDER 41 0.0212
322 OCULAR HYPERTENSION 41 0.0211
323 ULCER 336 0.0211
324 INFECTION 3012 0.0208
325 LYMPHOPROLIFERATIVE DISORDER 61 0.0207
326 IMMUNOSUPPRESSION 180 0.0204
327 PHYSICAL DISABILITY 90 0.0203
328 ALOPECIA 3973 0.0202
329 PAROSMIA 152 0.0201
330 ABSCESS INTESTINAL 43 0.0200
331 IMPAIRED QUALITY OF LIFE 285 0.0198
332 B-CELL LYMPHOMA 67 0.0197
333 GINGIVAL PAIN 156 0.0196
334 HYPOAESTHESIA 2900 0.0194
335 SUBILEUS 40 0.0192
336 LARGE INTESTINAL ULCER 52 0.0191
337 CREPITATIONS 57 0.0191
338 SOFT TISSUE INFECTION 35 0.0191
339 GROWTH RETARDATION 56 0.0190
340 PREGNANCY 380 0.0190
341 BASAL CELL CARCINOMA 295 0.0189
342 INFECTION SUSCEPTIBILITY INCREASED 41 0.0187
343 HYPERSENSITIVITY VASCULITIS 49 0.0186
344 CARDIAC MURMUR 161 0.0186
345 DYSPEPSIA 1816 0.0184
346 GENERALISED OEDEMA 228 0.0184
347 GLOMERULONEPHRITIS 45 0.0184
348 HYPERSENSITIVITY 3391 0.0182
349 SINUSITIS 1865 0.0182
350 NODULE 237 0.0181
351 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 32 0.0181
352 THROMBOCYTOSIS 66 0.0180
353 TUBULOINTERSTITIAL NEPHRITIS 335 0.0179
354 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
355 THERAPY PARTIAL RESPONDER 274 0.0175
356 COLECTOMY 99 0.0175
357 INTERVERTEBRAL DISCITIS 33 0.0175
358 HYPERCALCAEMIA 215 0.0174
359 IRON DEFICIENCY 78 0.0173
360 MIGRAINE 1655 0.0173
361 PUSTULE 41 0.0173
362 NECK PAIN 957 0.0171
363 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 85 0.0170
364 ADENOCARCINOMA 38 0.0169
365 PERIPHERAL SWELLING 2601 0.0169
366 HYPERTRANSAMINASAEMIA 117 0.0168
367 MYCOBACTERIUM AVIUM COMPLEX INFECTION 45 0.0167
368 SYNOVIAL CYST 77 0.0167
369 CONTUSION 1571 0.0163
370 DRUG ERUPTION 289 0.0163
371 LYMPHADENOPATHY MEDIASTINAL 31 0.0162
372 FEAR OF INJECTION 113 0.0158
373 BACK DISORDER 257 0.0158
374 HYPERTENSION 3342 0.0158
375 RECTAL HAEMORRHAGE 669 0.0156
376 SUBCUTANEOUS ABSCESS 74 0.0154
377 PRODUCT USE ISSUE 2892 0.0154
378 FOOT OPERATION 76 0.0153
379 CUTANEOUS VASCULITIS 56 0.0153
380 DIARRHOEA HAEMORRHAGIC 142 0.0152
381 TENDONITIS 235 0.0152
382 CONDITION AGGRAVATED 4537 0.0149
383 MICROCYTIC ANAEMIA 31 0.0149
384 AMYOTROPHIC LATERAL SCLEROSIS 32 0.0148
385 URTICARIA 2484 0.0148
386 PSORIASIS 1924 0.0147
387 CONFUSIONAL STATE 2379 0.0147
388 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 804 0.0146
389 RESPIRATORY DISORDER 438 0.0146
390 COLITIS 555 0.0146
391 HEAD DISCOMFORT 258 0.0146
392 GASTROOESOPHAGEAL REFLUX DISEASE 1153 0.0143
393 SKIN ULCER 370 0.0143
394 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 242 0.0142
395 AMNESIA 927 0.0142
396 PHOTOPHOBIA 267 0.0142
397 ADVERSE EVENT 1305 0.0141
398 ADVERSE DRUG REACTION 1268 0.0141
399 MENINGITIS ASEPTIC 63 0.0140
400 LUNG ADENOCARCINOMA 42 0.0139
401 KLEBSIELLA INFECTION 70 0.0138
402 DERMATITIS EXFOLIATIVE GENERALISED 48 0.0138
403 THERAPEUTIC RESPONSE DECREASED 814 0.0134
404 MEDICATION ERROR 743 0.0134
405 APHTHOUS ULCER 103 0.0133
406 UPPER RESPIRATORY TRACT INFECTION 612 0.0132
407 ULCERATIVE KERATITIS 36 0.0131
408 MUSCULAR WEAKNESS 1487 0.0131
409 NASOPHARYNGITIS 2394 0.0130
410 SKIN INFECTION 145 0.0129
411 LOSS OF EMPLOYMENT 39 0.0129
412 IRITIS 39 0.0128
413 KERATITIS 39 0.0128
414 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 49 0.0128
415 FISTULA 144 0.0128
416 OSTEOMYELITIS 231 0.0127
417 PNEUMOCYSTIS JIROVECII PNEUMONIA 128 0.0127
418 QUALITY OF LIFE DECREASED 170 0.0127
419 TUBERCULIN TEST POSITIVE 32 0.0126
420 ARTHRALGIA 5246 0.0126
421 ABSCESS 200 0.0125
422 COLITIS MICROSCOPIC 59 0.0124
423 IMPAIRED WORK ABILITY 265 0.0124
424 BACTERIAL SEPSIS 40 0.0123
425 ENDOMETRIOSIS 58 0.0122
426 MUSCULOSKELETAL DISORDER 231 0.0121
427 MEMORY IMPAIRMENT 1667 0.0121
428 HEPATOTOXICITY 269 0.0121
429 ADENOVIRUS INFECTION 35 0.0121
430 VAGINAL DISCHARGE 122 0.0120
431 WEIGHT FLUCTUATION 126 0.0120
432 DRUG LEVEL BELOW THERAPEUTIC 66 0.0120
433 ORGANISING PNEUMONIA 59 0.0119
434 PLATELET COUNT INCREASED 154 0.0118
435 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 345 0.0118
436 ABDOMINAL PAIN UPPER 2416 0.0117
437 TYPE IV HYPERSENSITIVITY REACTION 32 0.0117
438 WOUND COMPLICATION 40 0.0116
439 HEPATIC ENZYME ABNORMAL 58 0.0116
440 GASTROINTESTINAL INFLAMMATION 91 0.0116
441 WEIGHT INCREASED 2595 0.0116
442 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 32 0.0116
443 TONGUE ULCERATION 39 0.0115
444 HAEMATOCHEZIA 636 0.0115
445 HISTIOCYTOSIS HAEMATOPHAGIC 34 0.0114
446 INTESTINAL PERFORATION 128 0.0114
447 ASTHMA 1288 0.0114
448 DRUG LEVEL DECREASED 115 0.0113
449 BK VIRUS INFECTION 38 0.0113
450 ALTERED STATE OF CONSCIOUSNESS 244 0.0113
451 IMMUNE-MEDIATED MYOSITIS 31 0.0112
452 SMALL INTESTINAL OBSTRUCTION 136 0.0110
453 ORAL DISCOMFORT 153 0.0110
454 HERPES SIMPLEX 71 0.0109
455 EPSTEIN-BARR VIRUS INFECTION 68 0.0109
456 ABDOMINAL ABSCESS 48 0.0108
457 CLOSTRIDIUM DIFFICILE INFECTION 237 0.0108
458 RASH 4727 0.0108
459 SENSITIVITY TO WEATHER CHANGE 57 0.0108
460 DIPLOPIA 281 0.0108
461 PRODUCT USE IN UNAPPROVED INDICATION 2666 0.0107
462 GUILLAIN-BARRE SYNDROME 52 0.0107
463 HEPATIC STEATOSIS 199 0.0107
464 HYPOCALCAEMIA 202 0.0107
465 IRON DEFICIENCY ANAEMIA 98 0.0106
466 JOINT INJURY 226 0.0106
467 CLOSTRIDIUM DIFFICILE COLITIS 112 0.0106
468 ORAL CANDIDIASIS 139 0.0105
469 ENCEPHALITIS 73 0.0105
470 PRE-ECLAMPSIA 50 0.0105
471 MUSCLE SPASTICITY 129 0.0105
472 SPINAL PAIN 121 0.0103
473 SEPTIC SHOCK 449 0.0103
474 VASCULITIS 120 0.0103
475 PRESYNCOPE 250 0.0103
476 ASCITES 302 0.0103
477 IMMUNE THROMBOCYTOPENIA 47 0.0103
478 DECREASED APPETITE 2371 0.0102
479 GASTROENTERITIS VIRAL 184 0.0102
480 FIBROSIS 31 0.0101
481 MALIGNANT MELANOMA 134 0.0100
482 HAEMATEMESIS 251 0.0099
483 HYPOALBUMINAEMIA 76 0.0098
484 OFF LABEL USE 8523 0.0097
485 WHITE BLOOD CELL COUNT INCREASED 371 0.0097
486 MENINGITIS 64 0.0096
487 PARAESTHESIA ORAL 138 0.0096
488 FOOD INTOLERANCE 35 0.0095
489 GASTROINTESTINAL INFECTION 85 0.0095
490 PULMONARY TOXICITY 67 0.0095
491 DEPRESSION 2135 0.0094
492 SKIN REACTION 131 0.0093
493 OESOPHAGEAL CANDIDIASIS 37 0.0093
494 PEMPHIGOID 70 0.0093
495 OPTIC NEURITIS 84 0.0092
496 PYREXIA 3198 0.0092
497 ABDOMINAL PAIN 2139 0.0092
498 WOUND SECRETION 36 0.0092
499 INJECTION SITE REACTION 626 0.0091
500 CHOLANGITIS 56 0.0090
501 HERPES VIRUS INFECTION 52 0.0090
502 STREPTOCOCCAL INFECTION 50 0.0090
503 PSEUDOMONAS INFECTION 77 0.0090
504 SKIN PAPILLOMA 36 0.0090
505 PAIN IN EXTREMITY 2635 0.0089
506 PAIN 5476 0.0089
507 PARAESTHESIA 1394 0.0089
508 HAEMATURIA 303 0.0088
509 TINNITUS 406 0.0088
510 HYPERTENSIVE CRISIS 98 0.0088
511 PAPILLOEDEMA 39 0.0086
512 TONSILLITIS 45 0.0086
513 CHEST PAIN 1582 0.0085
514 OEDEMA PERIPHERAL 1032 0.0085
515 AUTOIMMUNE THYROIDITIS 32 0.0085
516 PANCREATITIS 447 0.0084
517 ABSCESS LIMB 36 0.0084
518 PNEUMONIA 2717 0.0084
519 ATELECTASIS 81 0.0084
520 RASH PRURITIC 449 0.0083
521 POST PROCEDURAL INFECTION 67 0.0082
522 INSOMNIA 2186 0.0082
523 RENAL CELL CARCINOMA 40 0.0082
524 VITAMIN B12 DEFICIENCY 33 0.0081
525 MALAISE 3562 0.0081
526 MOUTH ULCERATION 171 0.0081
527 UNDERDOSE 592 0.0081
528 DRUG INEFFECTIVE 10540 0.0080
529 BONE DENSITY DECREASED 250 0.0080
530 VISUAL IMPAIRMENT 988 0.0080
531 HYPOGAMMAGLOBULINAEMIA 52 0.0079
532 MUSCLE SPASMS 1436 0.0078
533 BLINDNESS 317 0.0078
534 AUTOIMMUNE HEPATITIS 54 0.0078
535 ERYSIPELAS 39 0.0078
536 SPINAL STENOSIS 32 0.0077
537 GASTROINTESTINAL TOXICITY 37 0.0077
538 TENDERNESS 80 0.0077
539 ANAL FISSURE 41 0.0076
540 LYMPHOPENIA 108 0.0076
541 ASPERGILLUS INFECTION 50 0.0076
542 MATERNAL EXPOSURE BEFORE PREGNANCY 52 0.0076
543 LYMPHADENOPATHY 269 0.0076
544 FOETAL DEATH 39 0.0075
545 SKIN LESION 206 0.0075
546 HEPATITIS B 45 0.0075
547 SQUAMOUS CELL CARCINOMA OF SKIN 45 0.0074
548 ENTEROCOCCAL INFECTION 36 0.0074
549 DEFAECATION URGENCY 52 0.0074
550 TACHYCARDIA 656 0.0074
551 UROSEPSIS 68 0.0074
552 ANAL INCONTINENCE 66 0.0073
553 DIFFUSE LARGE B-CELL LYMPHOMA 56 0.0073
554 LABORATORY TEST ABNORMAL 213 0.0072
555 VOMITING 3393 0.0072
556 GESTATIONAL DIABETES 34 0.0071
557 PULMONARY MASS 106 0.0071
558 FATIGUE 5533 0.0071
559 EAR DISORDER 32 0.0070
560 INTENTIONAL DOSE OMISSION 198 0.0069
561 FURUNCLE 55 0.0069
562 EYE PAIN 390 0.0069
563 ROSACEA 32 0.0069
564 OSTEOPENIA 103 0.0068
565 GAIT DISTURBANCE 1299 0.0068
566 RESPIRATORY TRACT INFECTION 176 0.0068
567 FLANK PAIN 63 0.0067
568 SKIN DISORDER 224 0.0067
569 EYE INFLAMMATION 64 0.0067
570 COVID-19 PNEUMONIA 79 0.0067
571 ESCHERICHIA INFECTION 55 0.0067
572 ARTHRITIS INFECTIVE 31 0.0067
573 SQUAMOUS CELL CARCINOMA 62 0.0066
574 SWOLLEN TONGUE 204 0.0065
575 ABDOMINAL DISTENSION 681 0.0065
576 HEADACHE 4071 0.0065
577 MUCOUS STOOLS 32 0.0065
578 ANAPHYLACTIC REACTION 356 0.0064
579 INTERSTITIAL LUNG DISEASE 311 0.0064
580 LOW BIRTH WEIGHT BABY 51 0.0064
581 HAEMATOCRIT DECREASED 127 0.0064
582 BRONCHITIS 474 0.0064
583 SKIN PLAQUE 54 0.0064
584 CYTOMEGALOVIRUS INFECTION 106 0.0064
585 DIARRHOEA 4107 0.0064
586 SYMPTOM RECURRENCE 38 0.0063
587 LIMB DISCOMFORT 194 0.0063
588 SERUM FERRITIN INCREASED 33 0.0063
589 ASPARTATE AMINOTRANSFERASE INCREASED 332 0.0062
590 ENTEROCOLITIS 36 0.0062
591 PROCTALGIA 40 0.0062
592 WEIGHT DECREASED 1731 0.0062
593 FOETAL EXPOSURE DURING PREGNANCY 504 0.0062
594 HEPATIC CYTOLYSIS 79 0.0062
595 ASTHENIA 2329 0.0062
596 BRONCHOPULMONARY ASPERGILLOSIS 48 0.0062
597 SPLENOMEGALY 72 0.0061
598 PRURITUS 2359 0.0061
599 SPINAL DISORDER 58 0.0061
600 DYSLIPIDAEMIA 31 0.0061
601 METASTASES TO LYMPH NODES 41 0.0061
602 RED BLOOD CELL COUNT DECREASED 173 0.0060
603 CARDIO-RESPIRATORY ARREST 253 0.0060
604 CONJUNCTIVITIS 112 0.0060
605 RETINAL HAEMORRHAGE 43 0.0060
606 ODYNOPHAGIA 36 0.0060
607 STAPHYLOCOCCAL INFECTION 198 0.0060
608 DRUG RESISTANCE 154 0.0060
609 HERPES ZOSTER 344 0.0060
610 LIVER FUNCTION TEST ABNORMAL 173 0.0059
611 NEUROLOGICAL SYMPTOM 34 0.0059
612 MALABSORPTION 31 0.0059
613 REBOUND EFFECT 67 0.0059
614 ALANINE AMINOTRANSFERASE INCREASED 364 0.0059
615 SEPSIS 661 0.0059
616 NEOPLASM 68 0.0059
617 HYPOKALAEMIA 272 0.0059
618 ABORTION INDUCED 55 0.0058
619 FEELING HOT 357 0.0058
620 PAPULE 41 0.0058
621 POSTOPERATIVE WOUND INFECTION 39 0.0058
622 CAESAREAN SECTION 67 0.0057
623 NEOPLASM MALIGNANT 383 0.0057
624 DIZZINESS 2861 0.0057
625 MALNUTRITION 64 0.0057
626 ECZEMA 298 0.0057
627 SWELLING OF EYELID 35 0.0056
628 ILEUS 69 0.0055
629 MULTIPLE FRACTURES 91 0.0055
630 COVID-19 969 0.0055
631 DECREASED IMMUNE RESPONSIVENESS 54 0.0055
632 TOOTH ABSCESS 56 0.0055
633 SCOLIOSIS 34 0.0055
634 ACCIDENTAL OVERDOSE 200 0.0055
635 DISEASE RECURRENCE 259 0.0054
636 TRANSAMINASES INCREASED 121 0.0054
637 LEUKOPENIA 271 0.0054
638 PREMATURE DELIVERY 86 0.0054
639 PLEURISY 32 0.0054
640 LYMPHOMA 83 0.0054
641 BOWEL MOVEMENT IRREGULARITY 41 0.0053
642 PNEUMONIA BACTERIAL 49 0.0053
643 CANDIDA INFECTION 90 0.0053
644 MYOCARDITIS 61 0.0053
645 COMA 253 0.0053
646 DERMATITIS ALLERGIC 66 0.0052
647 BLOOD DISORDER 42 0.0052
648 FLUID RETENTION 266 0.0052
649 CATARACT 309 0.0052
650 NAUSEA 4106 0.0052
651 PRODUCT QUALITY ISSUE 702 0.0052
652 NEPHROPATHY TOXIC 58 0.0052
653 GLAUCOMA 99 0.0051
654 PLEURAL EFFUSION 310 0.0051
655 PROCEDURAL PAIN 141 0.0051
656 RASH PUSTULAR 37 0.0051
657 NEUTROPHIL COUNT INCREASED 52 0.0051
658 CELLULITIS 255 0.0051
659 EXPOSURE VIA SKIN CONTACT 130 0.0050
660 BREAST CANCER STAGE I 46 0.0050
661 DUODENAL ULCER 35 0.0050
662 MASS 69 0.0049
663 GASTRIC DISORDER 169 0.0049
664 BLOOD PRESSURE SYSTOLIC INCREASED 95 0.0049
665 AORTIC ANEURYSM 37 0.0049
666 DEEP VEIN THROMBOSIS 315 0.0048
667 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
668 CARDIOVASCULAR DISORDER 123 0.0048
669 POLYNEUROPATHY 58 0.0048
670 SECRETION DISCHARGE 60 0.0048
671 DYSPNOEA 2707 0.0048
672 GASTROINTESTINAL PAIN 52 0.0047
673 FEMUR FRACTURE 146 0.0047
674 NIGHTMARE 161 0.0046
675 LYMPHOEDEMA 32 0.0046
676 SENSORY LOSS 37 0.0046
677 FACIAL PARALYSIS 39 0.0046
678 IMMUNE SYSTEM DISORDER 60 0.0045
679 BLOOD ALBUMIN DECREASED 36 0.0045
680 VITAMIN D DEFICIENCY 44 0.0045
681 ORAL HERPES 88 0.0045
682 BACTERAEMIA 53 0.0045
683 EOSINOPHILIA 78 0.0044
684 BLOOD TEST ABNORMAL 62 0.0044
685 RENAL TUBULAR NECROSIS 43 0.0044
686 RETINAL DETACHMENT 40 0.0043
687 ANXIETY 1234 0.0043
688 CYTOPENIA 53 0.0043
689 DRUG EFFECT LESS THAN EXPECTED 64 0.0043
690 MUCOSAL INFLAMMATION 113 0.0043
691 INTESTINAL OBSTRUCTION 162 0.0043
692 UNEVALUABLE EVENT 325 0.0043
693 BACTERIAL INFECTION 80 0.0043
694 PYELONEPHRITIS 37 0.0043
695 INCONTINENCE 45 0.0043
696 LEUKOCYTOSIS 76 0.0042
697 APPENDICITIS 39 0.0042
698 ABORTION SPONTANEOUS 167 0.0042
699 CARPAL TUNNEL SYNDROME 58 0.0041
700 VERTIGO 252 0.0041
701 SKIN CANCER 89 0.0041
702 CYST 51 0.0041
703 SARS-COV-2 TEST POSITIVE 54 0.0041
704 TREATMENT NONCOMPLIANCE 223 0.0041
705 LUNG INFILTRATION 36 0.0041
706 NERVE INJURY 45 0.0040
707 INTERVERTEBRAL DISC PROTRUSION 87 0.0040
708 ASPIRATION 43 0.0039
709 RESPIRATORY SYNCYTIAL VIRUS INFECTION 34 0.0039
710 TOXIC SKIN ERUPTION 39 0.0039
711 BODY TEMPERATURE INCREASED 79 0.0039
712 PHARYNGITIS 48 0.0039
713 PURPURA 34 0.0038
714 GASTROENTERITIS 56 0.0038
715 DEVICE RELATED INFECTION 59 0.0038
716 DERMATITIS 80 0.0038
717 PANCYTOPENIA 213 0.0038
718 OSTEONECROSIS OF JAW 94 0.0038
719 CHILLS 444 0.0038
720 HOSPITALISATION 568 0.0037
721 ERYTHEMA 748 0.0036
722 COLON CANCER 54 0.0036
723 BONE DISORDER 66 0.0036
724 DEAFNESS 94 0.0036
725 POST PROCEDURAL COMPLICATION 69 0.0036
726 BRAIN NEOPLASM 33 0.0036
727 PULMONARY EMBOLISM 341 0.0036
728 ISCHAEMIC STROKE 64 0.0036
729 VIRAL INFECTION 118 0.0035
730 LOCALISED INFECTION 85 0.0035
731 SYNCOPE 351 0.0035
732 FALL 1160 0.0035
733 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 33 0.0035
734 PREMATURE BABY 103 0.0034
735 GASTROINTESTINAL CARCINOMA 31 0.0034
736 BLOOD IRON DECREASED 40 0.0034
737 HEMIPARESIS 57 0.0034
738 HEPATOMEGALY 33 0.0034
739 DIVERTICULITIS 93 0.0034
740 KNEE OPERATION 33 0.0034
741 TOOTH INFECTION 44 0.0033
742 HIATUS HERNIA 43 0.0033
743 THERAPEUTIC RESPONSE SHORTENED 110 0.0033
744 ATAXIA 39 0.0033
745 SCAB 37 0.0032
746 PERITONITIS 67 0.0032
747 CARDIAC FAILURE 257 0.0032
748 PNEUMONITIS 87 0.0032
749 MYALGIA 541 0.0032
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 572 0.0032
751 OSTEONECROSIS 104 0.0032
752 THROMBOCYTOPENIA 353 0.0032
753 BLOOD CREATININE INCREASED 206 0.0032
754 DEVICE DEFECTIVE 54 0.0031
755 CARDIOMYOPATHY 46 0.0031
756 KIDNEY INFECTION 61 0.0031
757 URINARY TRACT INFECTION 528 0.0031
758 CHOLESTASIS 59 0.0031
759 HAEMOGLOBIN DECREASED 312 0.0030
760 PHOTOSENSITIVITY REACTION 50 0.0030
761 CYSTITIS 96 0.0030
762 RASH MACULO-PAPULAR 67 0.0030
763 MYELODYSPLASTIC SYNDROME 43 0.0030
764 PALPITATIONS 348 0.0030
765 NERVOUS SYSTEM DISORDER 92 0.0029
766 LOSS OF CONSCIOUSNESS 376 0.0029
767 FACE OEDEMA 49 0.0029
768 INTRAOCULAR PRESSURE INCREASED 37 0.0029
769 ACUTE MYELOID LEUKAEMIA 45 0.0029
770 ERECTILE DYSFUNCTION 74 0.0029
771 HAEMORRHOIDS 56 0.0029
772 SURGERY 168 0.0029
773 RENAL IMPAIRMENT 239 0.0028
774 PROTEINURIA 54 0.0028
775 PERICARDIAL EFFUSION 65 0.0028
776 ABDOMINAL PAIN LOWER 71 0.0028
777 RESPIRATORY FAILURE 204 0.0028
778 GASTRIC ULCER 53 0.0028
779 DEVICE MECHANICAL ISSUE 38 0.0028
780 RESPIRATORY TRACT CONGESTION 44 0.0028
781 ILLNESS 285 0.0028
782 MULTIPLE ORGAN DYSFUNCTION SYNDROME 78 0.0028
783 DIABETES MELLITUS 208 0.0027
784 BLOOD PRESSURE INCREASED 415 0.0027
785 ACUTE RESPIRATORY DISTRESS SYNDROME 48 0.0027
786 PANCREATITIS ACUTE 61 0.0027
787 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
788 MULTIPLE SCLEROSIS 128 0.0027
789 SWELLING FACE 174 0.0027
790 FEELING JITTERY 50 0.0026
791 BLINDNESS UNILATERAL 37 0.0026
792 SENSORY DISTURBANCE 42 0.0026
793 PRODUCT PRESCRIBING ISSUE 57 0.0026
794 BRAIN FOG 41 0.0026
795 ANAEMIA 498 0.0026
796 SPINAL FRACTURE 52 0.0026
797 COUGH 724 0.0026
798 BACK PAIN 596 0.0026
799 DEVICE MALFUNCTION 180 0.0026
800 GASTRITIS 67 0.0025
801 BREAST CANCER 237 0.0025
802 ANGIOEDEMA 112 0.0025
803 NEPHROLITHIASIS 115 0.0025
804 DRY EYE 124 0.0025
805 ACUTE MYOCARDIAL INFARCTION 73 0.0025
806 DYSGEUSIA 182 0.0024
807 SOMNOLENCE 477 0.0024
808 LUNG NEOPLASM MALIGNANT 97 0.0024
809 BEDRIDDEN 31 0.0024
810 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
811 PRODUCT SUBSTITUTION ISSUE 135 0.0023
812 FRACTURE 44 0.0023
813 PAIN IN JAW 65 0.0023
814 INFLUENZA 252 0.0023
815 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
816 SKIN HAEMORRHAGE 33 0.0022
817 DYSSTASIA 65 0.0022
818 DEPRESSED MOOD 117 0.0022
819 HYPERTHYROIDISM 32 0.0022
820 CEREBRAL HAEMORRHAGE 79 0.0022
821 DISEASE PROGRESSION 261 0.0022
822 OROPHARYNGEAL PAIN 204 0.0022
823 ACUTE KIDNEY INJURY 335 0.0022
824 HEPATOCELLULAR INJURY 31 0.0022
825 ACUTE RESPIRATORY FAILURE 42 0.0022
826 INTENTIONAL PRODUCT MISUSE 191 0.0022
827 VISION BLURRED 297 0.0022
828 DYSPHONIA 126 0.0022
829 HYPOKINESIA 31 0.0021
830 MOVEMENT DISORDER 68 0.0021
831 NEURALGIA 51 0.0021
832 MENTAL DISORDER 91 0.0021
833 THERAPY INTERRUPTED 149 0.0021
834 NEEDLE ISSUE 60 0.0021
835 FOOT FRACTURE 39 0.0021
836 RASH ERYTHEMATOUS 98 0.0020
837 FUNGAL INFECTION 67 0.0020
838 ORAL PAIN 45 0.0020
839 INCORRECT DOSE ADMINISTERED BY DEVICE 52 0.0020
840 LYMPHOCYTE COUNT DECREASED 35 0.0020
841 RENAL DISORDER 91 0.0020
842 DYSURIA 71 0.0019
843 EYE DISORDER 63 0.0019
844 DRUG DOSE OMISSION BY DEVICE 149 0.0019
845 INFLUENZA LIKE ILLNESS 156 0.0019
846 NEUROPATHY PERIPHERAL 180 0.0019
847 PRODUCTIVE COUGH 89 0.0019
848 RIB FRACTURE 38 0.0018
849 PNEUMONIA ASPIRATION 46 0.0018
850 LIMB INJURY 50 0.0018
851 OCULAR HYPERAEMIA 87 0.0018
852 RASH PAPULAR 41 0.0018
853 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
854 POOR QUALITY SLEEP 39 0.0018
855 MUSCULOSKELETAL DISCOMFORT 31 0.0018
856 CEREBRAL INFARCTION 43 0.0018
857 DYSPNOEA EXERTIONAL 66 0.0018
858 OVERDOSE 377 0.0017
859 EATING DISORDER 37 0.0017
860 DRUG EFFECT INCOMPLETE 63 0.0017
861 THROMBOSIS 139 0.0017
862 ACCIDENTAL EXPOSURE TO PRODUCT 170 0.0016
863 EYE SWELLING 61 0.0016
864 HEPATIC FUNCTION ABNORMAL 61 0.0016
865 DRUG INTERACTION 256 0.0016
866 ANAPHYLACTIC SHOCK 41 0.0016
867 CEREBROVASCULAR ACCIDENT 269 0.0016
868 ANGINA PECTORIS 45 0.0016
869 HYPOTENSION 315 0.0016
870 CHOLELITHIASIS 51 0.0016
871 PULMONARY HYPERTENSION 32 0.0015
872 HYPOTHYROIDISM 49 0.0015
873 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 80 0.0015
874 INJECTION SITE RASH 47 0.0015
875 FEEDING DISORDER 31 0.0015
876 FAECES DISCOLOURED 33 0.0015
877 PRODUCT DISPENSING ERROR 33 0.0015
878 COLORECTAL CANCER 72 0.0015
879 RHINORRHOEA 97 0.0015
880 BLOOD CREATINE PHOSPHOKINASE INCREASED 43 0.0015
881 HAEMORRHAGE 154 0.0015
882 BLOOD POTASSIUM DECREASED 44 0.0015
883 BREAST CANCER FEMALE 39 0.0015
884 RESPIRATORY DISTRESS 40 0.0014
885 SKIN EXFOLIATION 121 0.0014
886 HAEMOPTYSIS 40 0.0014
887 HYPOGLYCAEMIA 69 0.0014
888 NEUTROPENIA 193 0.0014
889 GASTROINTESTINAL HAEMORRHAGE 118 0.0014
890 DRUG EFFECT DECREASED 76 0.0014
891 DERMATITIS ATOPIC 74 0.0014
892 INJECTION SITE PRURITUS 92 0.0014
893 BLOOD BILIRUBIN INCREASED 37 0.0014
894 WHITE BLOOD CELL COUNT DECREASED 148 0.0014
895 NASAL CONGESTION 80 0.0014
896 RENAL FAILURE 179 0.0013
897 CONSTIPATION 293 0.0013
898 PROSTATE CANCER 107 0.0013
899 LACRIMATION INCREASED 40 0.0013
900 HAEMATOMA 34 0.0013
901 ENCEPHALOPATHY 32 0.0013
902 APHASIA 39 0.0013
903 HYPOPHAGIA 33 0.0013
904 PANCREATIC CARCINOMA 37 0.0013
905 ACNE 97 0.0013
906 CHRONIC KIDNEY DISEASE 97 0.0013
907 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
908 EYE IRRITATION 73 0.0013
909 INJECTION SITE SWELLING 95 0.0012
910 CARDIAC FAILURE CONGESTIVE 99 0.0012
911 THERAPEUTIC RESPONSE UNEXPECTED 55 0.0012
912 FEBRILE NEUTROPENIA 81 0.0012
913 PSYCHOTIC DISORDER 36 0.0012
914 BURNING SENSATION 85 0.0012
915 ATRIAL FIBRILLATION 118 0.0012
916 DEVICE DIFFICULT TO USE 80 0.0012
917 SEIZURE 139 0.0012
918 FEELING ABNORMAL 288 0.0012
919 LETHARGY 69 0.0012
920 INJECTION SITE PAIN 363 0.0012
921 HYPONATRAEMIA 66 0.0012
922 LIP SWELLING 39 0.0012
923 DEVICE DELIVERY SYSTEM ISSUE 32 0.0012
924 TOXICITY TO VARIOUS AGENTS 197 0.0012
925 ARRHYTHMIA 55 0.0012
926 FLATULENCE 65 0.0011
927 METABOLIC ACIDOSIS 36 0.0011
928 DEMENTIA 31 0.0011
929 DYSPHAGIA 104 0.0011
930 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37 0.0011
931 SUICIDAL IDEATION 100 0.0011
932 BALANCE DISORDER 94 0.0011
933 VISUAL ACUITY REDUCED 36 0.0011
934 TREMOR 179 0.0011
935 HYPERHIDROSIS 138 0.0011
936 COGNITIVE DISORDER 50 0.0011
937 RENAL CANCER 51 0.0011
938 RASH MACULAR 37 0.0011
939 INJECTION SITE ERYTHEMA 130 0.0010
940 CRYING 38 0.0010
941 THERAPY CESSATION 53 0.0010
942 HYPERGLYCAEMIA 37 0.0010
943 PANIC ATTACK 37 0.0010
944 INJECTION SITE BRUISING 80 0.0010
945 PRODUCT DOSE OMISSION ISSUE 293 0.0010
946 CARDIAC DISORDER 93 0.0010
947 URINARY RETENTION 33 0.0010
948 THROAT IRRITATION 44 0.0010
949 DEATH 816 0.0009
950 DEVICE LEAKAGE 41 0.0009
951 SPEECH DISORDER 49 0.0009
952 RHABDOMYOLYSIS 39 0.0009
953 PULMONARY OEDEMA 41 0.0009
954 POLLAKIURIA 37 0.0009
955 DEVICE ISSUE 79 0.0009
956 IRRITABILITY 52 0.0009
957 BLADDER CANCER 50 0.0008
958 NO ADVERSE EVENT 151 0.0008
959 DRY SKIN 109 0.0008
960 SUICIDE ATTEMPT 49 0.0008
961 SKIN DISCOLOURATION 37 0.0008
962 EPISTAXIS 60 0.0008
963 INJECTION SITE HAEMORRHAGE 62 0.0008
964 DEHYDRATION 103 0.0008
965 HEART RATE INCREASED 75 0.0008
966 CHEST DISCOMFORT 77 0.0008
967 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35 0.0007
968 FLUSHING 76 0.0007
969 HYPOACUSIS 32 0.0007
970 MYOCARDIAL INFARCTION 129 0.0007
971 CARDIAC ARREST 54 0.0007
972 HOT FLUSH 47 0.0006
973 INCORRECT DOSE ADMINISTERED 121 0.0005
974 SKIN BURNING SENSATION 37 0.0005
975 AGITATION 37 0.0005
976 PRODUCT STORAGE ERROR 41 0.0005
977 DRUG DEPENDENCE 71 0.0004
978 COMPLETED SUICIDE 36 0.0004
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 84 0.0004
980 HALLUCINATION 31 0.0004
981 BLOOD GLUCOSE INCREASED 52 0.0003
982 EMOTIONAL DISTRESS 32 0.0003